1. 115. N-methyl-2-pyrrolidinone. Nordic expert group for criteria documentation of health risks from chemicals;Akesson, B.,1994
2. Percutaneous absorption of coadministered N-methyl-2-[G4C]pyrrolidinone and 2- ['4C]pyrrolidinone 3 14C in;Midgley, I.; Hood, A.J.; Chasseaud, L.F.; Brindley, C.J.; Baughman, S.; Allan, G.;the rat. Fd Chem Toxicol,1992
3. The kinetics of N-methyl-2-pyrrolidinone in pregnant rats and their foetuses compared with non-pregnant rats;Ravn-Jonsen, A.; Edelfors, S.; Hass, U.; Lund, S.P.,1992
4. Disposition and metabolism of double-labeled [3H and 'IC] N-methyl-2-pyrrolidinone in the rat;Wells, D.A.; Digenis, G.A.;Drug Metab Dispos,1988
5. Isolation and identification of the major urinary metabolise of NMP in the rat;Wells, D.A.; Hawi, A.A.; Digenis, G.A.;Drug Metab Dispos,1992